Postmenopausal Breast Cancer

This publication has 99 references indexed in Scilit:

• Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer
  European Journal of Cancer and Clinical Oncology, 1991
• A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the north central cancer treatment group and mayo clinic
  Cancer, 1991
• A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1990
• Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast Cancer
  New England Journal of Medicine, 1989
• Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
  New England Journal of Medicine, 1988
• Improving the Quality of Life during Chemotherapy for Advanced Breast Cancer
  New England Journal of Medicine, 1987
• On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer
  Journal of Molecular Medicine, 1987
• High-dose medroxyprogesterone acetate in combination with vindesine in advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1986
• Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer
  Breast Cancer Research and Treatment, 1985
• A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer
  Breast Cancer Research and Treatment, 1983